Australian Racing Board Announces Ban on Anabolic Steroids in Horse Racing

by Thilaka Ravi on September 18, 2013 at 10:34 AM
Australian Racing Board Announces Ban on Anabolic Steroids in Horse Racing

The Australian Racing Board has reportedly announced a ban on anabolic steroids. The ban will apply to horses both in and out of competition from the age of six months, with that period allowed in the interests of animal welfare.

According to The Independent, the new rule will be introduced on November 1, with the ban taking effect from May 1 next year to give any treated horses six months to be clear of the drugs.


The report mentioned that under current rules, steroids are prohibited in horses only on race day.

The announcement came in the wake of the Mahmood al-Zarooni scandal, following which the British Horseracing Authority has been vocal in opposing the use of steroids and has raised the issue for worldwide discussion.

Mahmood Al Zarooni was an Emirati horse-racing trainer at the Godolphin horse-racing operation, who had confessed to doping 11 prize thoroughbreds belonging to Dubai's ruler Sheikh Mohammed, and has been banned for eight years in a scandal, which is reportedly the biggest in the sport of horse racing, reports said.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Australian Racing Board Announces Ban on Anabolic Steroids in Horse Racing Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests